C957T

Last updated

The C957T gene polymorphism is a synonymous mutation located within the 957th base pair of the DRD2 gene. This base pair is located in exon 7. Most synonymous mutations are silent. However, the C957T mutation is an exception to this rule. While the 957C allele codes for the same polypeptide as the 957T allele, the conformation of 957T messenger RNA differs from the conformation of 957C messenger RNA. 957T messenger RNA is less stable and more prone to degradation. Dopamine D2 receptor expression is increased among individuals who carry the 957T allele compared to individuals who carry the 957C allele (in contrast to the original article publication, which has since been corrected). [1] [2]

Contents


Behaviours associated with the C/C genotype of the C957T polymorphism

Given that the C/C genotype has been associated with dissocial personality disorder one may infer that this genotype may also be associated with all four DSM-IV defined cluster B personality disorders. This hypothesis, however, has not been tested.

Rapid screening of the C957T and the TaqIA polymorphisms

Given the importance of the C957T and TaqIA polymorphisms for the diagnosis and treatment of psychological disorder, a rapid screening protocol for these genes has been developed. [14] Since the DRD2 1101A allele nulls the effects of the 957T allele, [15] screens for the 957C allele which ignore the 1101A allele can sometimes lead to false negatives.

Related Research Articles

<span class="mw-page-title-main">Serotonin transporter</span> Mammalian protein found in humans

The serotonin transporter also known as the sodium-dependent serotonin transporter and solute carrier family 6 member 4 is a protein that in humans is encoded by the SLC6A4 gene. SERT is a type of monoamine transporter protein that transports the neurotransmitter serotonin from the synaptic cleft back to the presynaptic neuron, in a process known as serotonin reuptake.

Schizotypal personality disorder, also known as schizotypal disorder, is a cluster A personality disorder. The Diagnostic and Statistical Manual of Mental Disorders (DSM) classification describes the disorder specifically as a personality disorder characterized by thought disorder, paranoia, a characteristic form of social anxiety, derealization, transient psychosis, and unconventional beliefs. People with this disorder feel pronounced discomfort in forming and maintaining social connections with other people, primarily due to the belief that other people harbor negative thoughts and views about them. Peculiar speech mannerisms and socially unexpected modes of dress are also characteristic. Schizotypal people may react oddly in conversations, not respond, or talk to themselves. They frequently interpret situations as being strange or having unusual meanings for them; paranormal and superstitious beliefs are common. Schizotypal people usually disagree with the suggestion that their thoughts and behaviors are a 'disorder' and seek medical attention for depression or anxiety instead. Schizotypal personality disorder occurs in approximately 3% of the general population and is more commonly diagnosed in males.

The dopamine hypothesis of schizophrenia or the dopamine hypothesis of psychosis is a model that attributes the positive symptoms of schizophrenia to a disturbed and hyperactive dopaminergic signal transduction. The model draws evidence from the observation that a large number of antipsychotics have dopamine-receptor antagonistic effects. The theory, however, does not posit dopamine overabundance as a complete explanation for schizophrenia. Rather, the overactivation of D2 receptors, specifically, is one effect of the global chemical synaptic dysregulation observed in this disorder.

Catechol-<i>O</i>-methyltransferase Class of enzymes

Catechol-O-methyltransferase is one of several enzymes that degrade catecholamines, catecholestrogens, and various drugs and substances having a catechol structure. In humans, catechol-O-methyltransferase protein is encoded by the COMT gene. Two isoforms of COMT are produced: the soluble short form (S-COMT) and the membrane bound long form (MB-COMT). As the regulation of catecholamines is impaired in a number of medical conditions, several pharmaceutical drugs target COMT to alter its activity and therefore the availability of catecholamines. COMT was first discovered by the biochemist Julius Axelrod in 1957.

<span class="mw-page-title-main">Dopamine receptor</span> Class of G protein-coupled receptors

Dopamine receptors are a class of G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS). Dopamine receptors activate different effectors through not only G-protein coupling, but also signaling through different protein interactions. The neurotransmitter dopamine is the primary endogenous ligand for dopamine receptors.

<span class="mw-page-title-main">Methylenetetrahydrofolate reductase</span> Rate-limiting enzyme in the methyl cycle

Methylenetetrahydrofolatereductase (MTHFR) is the rate-limiting enzyme in the methyl cycle, and it is encoded by the MTHFR gene. Methylenetetrahydrofolate reductase catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a cosubstrate for homocysteine remethylation to methionine. Natural variation in this gene is common in otherwise healthy people. Although some variants have been reported to influence susceptibility to occlusive vascular disease, neural tube defects, Alzheimer's disease and other forms of dementia, colon cancer, and acute leukemia, findings from small early studies have not been reproduced. Some mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency. Complex I deficiency with recessive spastic paraparesis has also been linked to MTHFR variants. In addition, the aberrant promoter hypermethylation of this gene is associated with male infertility and recurrent spontaneous abortion.

The hunter versus farmer hypothesis is a proposed explanation of the nature of attention-deficit hyperactivity disorder (ADHD) first suggested by radio host Thom Hartmann in his book Attention Deficit Disorder: A Different Perception. This hypothesis proposes that ADHD represents a lack of adaptation of members of hunter-gatherer societies to their transformation into farming societies. Hartmann developed the idea first as a mental model after his own son was diagnosed with ADHD, stating, "It's not hard science, and was never intended to be."

Dopamine receptor D<sub>4</sub> Protein-coding gene in the species Homo sapiens

The dopamine receptor D4 is a dopamine D2-like G protein-coupled receptor encoded by the DRD4 gene on chromosome 11 at 11p15.5.

Gene–environment correlation is said to occur when exposure to environmental conditions depends on an individual's genotype.

Dopamine receptor D<sub>2</sub> Main receptor for most antipsychotic drugs

Dopamine receptor D2, also known as D2R, is a protein that, in humans, is encoded by the DRD2 gene. After work from Paul Greengard's lab had suggested that dopamine receptors were the site of action of antipsychotic drugs, several groups, including those of Solomon Snyder and Philip Seeman used a radiolabeled antipsychotic drug to identify what is now known as the dopamine D2 receptor. The dopamine D2 receptor is the main receptor for most antipsychotic drugs. The structure of DRD2 in complex with the atypical antipsychotic risperidone has been determined.

<span class="mw-page-title-main">Dopamine beta-hydroxylase</span> Mammalian protein found in Homo sapiens

Dopamine beta-hydroxylase (DBH), also known as dopamine beta-monooxygenase, is an enzyme that in humans is encoded by the DBH gene. Dopamine beta-hydroxylase catalyzes the conversion of dopamine to norepinephrine.

Dopamine receptor D<sub>1</sub> Protein-coding gene in the species Homo sapiens

Dopamine receptor D1, also known as DRD1. It is one of the two types of D1-like receptor family - receptors D1 and D5. It is a protein that in humans is encoded by the DRD1 gene.

Dopamine receptor D<sub>5</sub> Protein-coding gene in the species Homo sapiens

Dopamine receptor D5, also known as D1BR, is a protein that in humans is encoded by the DRD5 gene. It belongs to the D1-like receptor family along with the D1 receptor subtype.

Dopamine receptor D<sub>3</sub> Subtype of the dopamine receptor protein

Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene.

rs6295, also called C(-1019)G, is a gene variation—a single nucleotide polymorphism (SNP)—in the HTR1A gene. It is one of the most investigated SNPs of its gene. The C-allele is the most prevalent with 0.675 against the G-allele with 0.325 among Caucasian.

In genetics, rs1800955 is a single nucleotide polymorphism (SNP). It is located in the promoter region of the DRD4 gene. This gene codes for the dopamine receptor D4.

The Haplotype-relative-risk (HRR) method is a family-based method for determining gene allele association to a disease in the presence of actual genetic linkage. Nuclear families with one affected child are sampled using the parental haplotypes not transmitted as a control. While similar to the genotype relative risk (RR), the HRR provides a solution to the problem of population stratification by only sampling within family trios. The HRR method was first proposed by Rubinstein in 1981 then detailed in 1987 by Rubinstein and Falk and is an important tool in genetic association studies.

The causes of schizophrenia that underlie the development of schizophrenia, a psychiatric disorder, are complex and not clearly understood. A number of hypotheses including the dopamine hypothesis, and the glutamate hypothesis have been put forward in an attempt to explain the link between altered brain function and the symptoms and development of schizophrenia.

<span class="mw-page-title-main">ANKK1</span> Protein-coding gene in the species Homo sapiens

Ankyrin repeat and kinase domain containing 1 (ANKK1) also known as protein kinase PKK2 or sugen kinase 288 (SgK288) is an enzyme that in humans is encoded by the ANKK1 gene. The ANKK1 is a member of an extensive family of the Ser/Thr protein kinase family, and protein kinase superfamily involved in signal transduction pathways.

The genetic influences of post-traumatic stress disorder are not understood well due to the limitations of any genetic study of mental illness; in that, it cannot be ethically induced in selected groups. Because of this, all studies must use naturally occurring groups with genetic similarities and differences, thus the amount of data is limited. However, genetics play some role in the development of PTSD. Approximately 30% of the variance in PTSD is caused by genetics alone. For twin pairs exposed to combat in Vietnam, having a monozygotic (identical) twin with PTSD was associated with an increased risk of the co-twin's having PTSD compared to twins that were dizygotic ; additionally, assaultive trauma, compared to non-assaultive trauma, was more likely to exacerbate these effects.

References

  1. ↑ Hirvonen, M; Laakso, A; Någren, K; Rinne, J O; Pohjalainen, T; Hietala, J (2004). "C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo". Molecular Psychiatry. 9 (12): 1060–1061. doi: 10.1038/sj.mp.4001561 . ISSN   1359-4184. PMID   15278099.
  2. ↑ Hirvonen, M (25 August 2005). "Erratum: C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo". Molecular Psychiatry. 10 (889). doi: 10.1038/sj.mp.4001707 . Retrieved 16 March 2023.
  3. ↑ Lawford, Bruce R. (2005). "The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia" (PDF). Schizophrenia Research. 73 (1): 31–37. doi:10.1016/j.schres.2004.08.020. PMID   15567074. S2CID   14885436.
  4. ↑ Hänninen, Kari (2006). "Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia". Neuroscience Letters. 407 (3): 195–198. doi:10.1016/j.neulet.2006.08.041. PMID   16973280. S2CID   42733897.
  5. ↑ Xu, H; Kellendonk, CB; Simpson, EH; Keilp, JG; Bruder, GE; Polan, HJ; Kandel, ER; Gilliam, TC (2007). "DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability". Schizophrenia Research. 90 (1–3): 104–107. doi:10.1016/j.schres.2006.10.001. PMID   17113268. S2CID   14189016.
  6. ↑ Jacobsen LK, Pugh KR, Mencl WE, Gelernter J (2006). "C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency". Psychopharmacology. 188 (4): 530–40. doi:10.1007/s00213-006-0469-1. PMID   16896957. S2CID   21282840.
  7. ↑ White MJ, Lawford BR, Morris CP, Young RM (2009). "Interaction between DRD2 C957T polymorphism and an acute psychosocial stressor on reward-related behavioral impulsivity" (PDF). Behav. Genet. 39 (3): 285–95. doi:10.1007/s10519-008-9255-7. PMID   19148742. S2CID   9125225.
  8. ↑ Eny, Karen M.; Corey, Paul N.; El-Sohemy, Ahmed (2009). "Dopamine D2 Receptor Genotype (C957T) and Habitual Consumption of Sugars in a Free-Living Population of Men and Women". Journal of Nutrigenetics and Nutrigenomics. 2 (4–5): 235–242. doi: 10.1159/000276991 . ISSN   1661-6758. PMID   20357494. S2CID   25531156.
  9. ↑ Cambridge Journals Online - Abstract
  10. ↑ Mo, GH; Lai, IC; Wang, YC; Chen, JY; Lin, CY; Chen, TT; Chen, ML; Liou, YJ; Liao, DL; Bai, YM; Lin, CC (2007). "Support for an association of the C939T polymorphism in the human DRD2 gene with tardive dyskinesia in schizophrenia". Schizophrenia Research. 97 (1–3): 302–304. doi:10.1016/j.schres.2007.06.026. PMID   17669630. S2CID   37815421.
  11. ↑ Huertas, E. (2010). "The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming". Genes, Brain and Behavior. 9 (1): 103–109. doi:10.1111/j.1601-183X.2009.00543.x. PMID   19900188.
  12. ↑ Ponce, G.; Hoenicka, J.; Jiménez-Arriero, M. A.; Rodríguez-Jiménez, R.; Aragüés, M.; Martín-Suñé, N.; Huertas, E.; Palomo, T. (2018). "DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: Association and interaction study". British Journal of Psychiatry. 193 (2): 121–125. doi: 10.1192/bjp.bp.107.041582 . ISSN   0007-1250. PMID   18669994.
  13. ↑ Voisey, Joanne (2009). "The DRD2 gene 957C>T polymorphism is associated with Posttraumatic Stress Disorder in war veterans" (PDF). Depression and Anxiety. 26 (1): 28–33. doi:10.1002/da.20517. PMID   18833581. S2CID   1698669.>T polymorphism is associated with Posttraumatic Stress Disorder in war veterans - Voisey - 2008 - Depression and Anxiety - Wiley Online Library]
  14. ↑ Stefan P, Moritz E, Alexander W, Weber M, Norbert D, Annette W, Thomas F, Andreas P (2009). "Development of a high-throughput method for screening the dopamine D2 (DRD2) receptor gene polymorphisms based on the LightCycler system". Clinical Laboratory. 55 (9–10): 353–8. PMID   20099571.
  15. ↑ Duan, J. (2003). "Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor". Human Molecular Genetics. 12 (3): 205–216. doi: 10.1093/hmg/ddg055 . ISSN   1460-2083. PMID   12554675.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.